Literature DB >> 31111143

Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study.

Seyed-Mohammad Fereshtehnejad1,2,3, Chun Yao4, Amelie Pelletier5, Jacques Y Montplaisir6,7, Jean-François Gagnon6,8, Ronald B Postuma1,6.   

Abstract

Parkinson's disease has a long prodromal stage with various subclinical motor and non-motor manifestations; however, their evolution in the years before Parkinson's disease is diagnosed is unclear. We traced the evolution of early motor and non-motor manifestations of synucleinopathy from the stage of idiopathic rapid eye movement (REM) sleep behaviour disorder until defined neurodegenerative disease. During 2004-16, we recruited and then annually followed 154 polysomnography-proven patients with idiopathic REM sleep behaviour disorder, of whom 55 phenoconverted to defined parkinsonism or dementia. Longitudinal data on multiple prodromal features, including the Unified Parkinson's Disease Rating Scale parts I-III, quantitative motor tests, olfaction, colour vision, cognition, and autonomic functions were gathered annually (average = five follow-up visits, range: 2-12 years). The same measures were also assessed in 102 age- and sex-matched healthy control subjects. By looking backward from the time of dementia or parkinsonism diagnosis, we examined trajectories of each prodromal feature using mixed effect models. Based on analysis, olfactory loss was first to develop, with predicted onset >20 years before phenoconversion. This was followed by impaired colour vision, constipation, and erectile dysfunction, starting 10-16 years prior to phenoconversion. At 7-9 years before phenoconversion, slight urinary dysfunction and subtle cognitive decline could be detected. Among motor symptoms altered handwriting, turning in bed, walking, salivation, speech, and facial expression began to be disrupted starting 7-11 years prior to parkinsonism diagnosis, but remained mild until soon before phenoconversion. Motor examination abnormalities began 5-7 years before phenoconversion, with the alternate tap test having the longest interval (8 years before phenoconversion). Among cardinal motor phenotypes, bradykinesia appeared first, ∼5-6 years prior to phenoconversion, followed by rigidity (Year -3) and tremor (Year -2). With direct prospective evaluation of an idiopathic REM sleep behaviour disorder cohort during phenoconversion, we documented an evolution of prodromal manifestations similar to that predicted by pathological staging models, with predicted prodromal intervals as long as 20 years.
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  evolution; parkinsonism; prodromal stage; rapid-eye-movement (REM) sleep behaviour disorder (RBD)

Mesh:

Year:  2019        PMID: 31111143     DOI: 10.1093/brain/awz111

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  57 in total

1.  Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model.

Authors:  Indrani Datta; S R Mekha; Alka Kaushal; Kavina Ganapathy; Rema Razdan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-29       Impact factor: 3.000

2.  REM sleep without atonia is associated with increased rigidity in patients with mild to moderate Parkinson's disease.

Authors:  Maria E Linn-Evans; Matthew N Petrucci; Sommer L Amundsen Huffmaster; Jae Woo Chung; Paul J Tuite; Michael J Howell; Aleksandar Videnovic; Colum D MacKinnon
Journal:  Clin Neurophysiol       Date:  2020-05-12       Impact factor: 3.708

3.  Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Lancet Neurol       Date:  2019-10-31       Impact factor: 44.182

4.  Onset of Skin, Gut, and Genitourinary Prodromal Parkinson's Disease: A Study of 1.5 Million Veterans.

Authors:  Gregory D Scott; Miranda M Lim; Matthew G Drake; Randy Woltjer; Joseph F Quinn
Journal:  Mov Disord       Date:  2021-05-03       Impact factor: 10.338

5.  The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.

Authors:  Emma Biondetti; Mathieu D Santin; Romain Valabrègue; Graziella Mangone; Rahul Gaurav; Nadya Pyatigorskaya; Matthew Hutchison; Lydia Yahia-Cherif; Nicolas Villain; Marie-Odile Habert; Isabelle Arnulf; Smaranda Leu-Semenescu; Pauline Dodet; Miquel Vila; Jean-Christophe Corvol; Marie Vidailhet; Stéphane Lehéricy
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

Review 6.  Motor Dysfunction in REM Sleep Behavior Disorder: A Rehabilitation Framework for Prodromal Synucleinopathy.

Authors:  Rebekah L S Summers; Miriam R Rafferty; Michael J Howell; Colum D MacKinnon
Journal:  Neurorehabil Neural Repair       Date:  2021-05-12       Impact factor: 3.919

7.  REM Sleep Without Atonia and Gait Impairment in People with Mild-to-Moderate Parkinson's Disease.

Authors:  Sommer L Amundsen-Huffmaster; Matthew N Petrucci; Maria E Linn-Evans; Jae Woo Chung; Michael J Howell; Aleksandar Videnovic; Paul J Tuite; Scott E Cooper; Colum D MacKinnon
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

8.  White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson's Disease.

Authors:  Mahsa Dadar; Seyed-Mohammad Fereshtehnejad; Yashar Zeighami; Alain Dagher; Ronald B Postuma; D Louis Collins
Journal:  Mov Disord Clin Pract       Date:  2020-07-18

Review 9.  Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.

Authors:  Mitchell G Miglis; Charles H Adler; Elena Antelmi; Dario Arnaldi; Luca Baldelli; Bradley F Boeve; Matteo Cesari; Irene Dall'Antonia; Nico J Diederich; Kathrin Doppler; Petr Dušek; Raffaele Ferri; Jean-François Gagnon; Ziv Gan-Or; Wiebke Hermann; Birgit Högl; Michele T Hu; Alex Iranzo; Annette Janzen; Anastasia Kuzkina; Jee-Young Lee; Klaus L Leenders; Simon J G Lewis; Claudio Liguori; Jun Liu; Christine Lo; Kaylena A Ehgoetz Martens; Jiri Nepozitek; Giuseppe Plazzi; Federica Provini; Monica Puligheddu; Michal Rolinski; Jan Rusz; Ambra Stefani; Rebekah L S Summers; Dallah Yoo; Jennifer Zitser; Wolfgang H Oertel
Journal:  Lancet Neurol       Date:  2021-08       Impact factor: 44.182

10.  Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on Aging.

Authors:  Chun W Yao; Amélie Pelletier; Seyed-Mohammad Fereshtehnejad; Nathan Cross; Thanh Dang-Vu; Ronald B Postuma
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.